The appointment of Mass General Hospital obesity doctor Dr. Fatima Cody Stanford to the DGAC suggests that Biden’s big government is collaborating with billion-dollar Big Pharma to shape the new obesity policy.
Conflicts of interest and potential corruption apparently exist in every corner of the Biden administration. As the 2025 Dietary Guidelines Advisory Committee (DGAC) begins its review of the Dietary Guidelines for Americans, a process that occurs every five years, Senator Chuck Grassley has disclosed that at least one committee member has significant ties to Big Pharma. In a March 17 letter to the Secretaries of the Department of Health and Human Services and the Department of Agriculture, Grassley highlighted the failure of both agencies to follow the recommendations from the National Academies of Science, Engineering, and Medicine—as requested by Congress—which explicitly call for public transparency for any known conflicts of interest.
Realizing a lucrative relationship with the drug industry, the appointment of Mass General Hospital obesity doctor Dr. Fatima Cody Stanford to the DGAC suggests that Biden’s big government is collaborating with billion-dollar Big Pharma to manipulate the Dietary Guidelines. Minimizing the importance of a proper diet when addressing obesity, Dr. Stanford, who is also a professor at Harvard Medical School, asserts that the number one cause of obesity is genetics. As such, as stated in an interview with the New York Times, Dr. Stanford is advocating for a bill called The Treat and Reduce Obesity Act which would require Medicare to cover anti-obesity drugs like the one she has been paid tens of thousands of dollars to promote. Obesity might be tied to genetics, but Stanford’s involvement on the panel is suspicious.
More than half of the world’s population will be overweight or obese by 2035 without significant action, according to a new report.
You can read more about this topic here.
Support GreatGameIndia
